Open Access

Comparative study of low dose of capecitabine versus standard dose in metastatic breast cancer: Efficacy and safety

Engy M Aboelnaga

Engy M Aboelnaga

Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Mansoura UniversityEgypt
Search for this author on
Sciendo|Google Scholar
Aboelnaga, Engy M
 and 
Wafaa El-beshbishi

Wafaa El-beshbishi

Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Mansoura UniversityEgypt
Search for this author on
Sciendo|Google Scholar
El-beshbishi, Wafaa
  
Aug 09, 2021
Comparative study of low dose of capecitabine versus standard dose in metastatic breast cancer: Efficacy and safety's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Research Article
Published Online: Aug 09, 2021
Page range: 12 - 21
Received: Jul 05, 2019
Accepted: Nov 05, 2019
DOI: https://doi.org/10.2478/fco-2019-0015
Keywords
© 2021 Engy M Aboelnaga et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology
Journal RSS Feed